Showing results (1231-1240 of 4,380) with videos related to
Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|July 24, 2018
LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor ActivityZahid Q Bonday, Guillermo S Cortez, Michael J Grogan, et al.ACS Medicinal Chemistry Letters|July 24, 2018
Plasmin-Binding Tripeptide-Decorated Liposomes Loading Pyrazolo[3,4-d]pyrimidines for Targeting Hepatocellular CarcinomaPierpaolo Calandro, Giulia Iovenitti, Claudio Zamperini, et al.ACS Medicinal Chemistry Letters|July 24, 2018
Sweet Binders: Carbonic Anhydrase IX in Complex with SucraloseCarrie L Lomelino, Akilah B Murray, Claudiu T Supuran, et al.ACS Medicinal Chemistry Letters|July 24, 2018
Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of AsthmaXianhai Huang, Jason Brubaker, Wei Zhou, et al.ACS Medicinal Chemistry Letters|July 24, 2018
Discovery of an Orally Bioavailable Dual PI3K/mTOR Inhibitor Based on Sulfonyl-Substituted MorpholinopyrimidinesSida Shen, Xiangyu He, Zheng Yang, et al.ACS Medicinal Chemistry Letters|July 24, 2018
Optimization of ZD2 Peptide Targeted Gd(HP-DO3A) for Detection and Risk-Stratification of Prostate Cancer with MRINadia R Ayat, Jing-Can Qin, Han Cheng, et al.ACS Medicinal Chemistry Letters|July 24, 2018
Reverse Hydroxamate Inhibitors of Bone Morphogenetic Protein 1Lara S Kallander, David Washburn, Mark A Hilfiker, et al.ACS Medicinal Chemistry Letters|July 24, 2018
Using Tumor Explants for Imaging Mass Spectrometry Visualization of Unlabeled Peptides and Small MoleculesBrian P David, Oleksii Dubrovskyi, Thomas E Speltz, et al.ACS Medicinal Chemistry Letters|May 26, 2018
Academic Drug Development: The DRIVE ModelDennis Liotta, George PainterACS Medicinal Chemistry Letters|May 26, 2018
What Do You Get from DNA-Encoded Libraries?Alexander L SatzPageof 438